Elite Health Systems Reports Revenue Growth and Increased Losses in Q2 2026

Elite Health Systems Inc. reported its financial results for the second quarter and first half of 2026, revealing a significant increase in revenue attributed to its recent operational activities. For the three months ended June 30, 2026, the company generated revenue of $1.31 million, compared to no revenue in the same period of 2025. For the six months ended June 30, 2026, total revenue reached $2.71 million, again reflecting a substantial increase from zero in the prior year. However, the company also reported a net loss of $1.53 million for the second quarter and $2.83 million for the first half of 2026, compared to losses of $441,000 and $865,000, respectively, in the same periods of 2025.

The financial performance indicates a marked increase in operational costs, particularly in selling, general, and administrative expenses, which rose to $1.71 million for the second quarter and $3.12 million for the first half of 2026, compared to $445,000 and $872,000 in the respective periods of 2025. This increase is largely attributed to the acquisition of Physician Support Systems, Inc. (PSS) and the operational launch of its Medicare Advantage plans, which began onboarding members in October 2025. The company’s accumulated deficit also grew to $15.08 million as of June 30, 2026, up from $12.25 million at the end of 2025.

In terms of strategic developments, Elite Health Systems completed the acquisition of PSS in November 2025, which has contributed to its revenue generation capabilities. The company has also received state and federal approvals to operate as a Medicare Advantage plan, which it began on January 1, 2026. The operational focus is now on expanding its member base in California, with plans to eventually apply for licenses in Nevada and other states. The company has reported a total of 28.52 million shares outstanding as of June 30, 2026, following its capital-raising efforts.

Operationally, the company has seen a shift in its business model, with the introduction of Medicare Advantage plans leading to new revenue streams. The company reported policy revenue of $162,000 for the second quarter of 2026, reflecting its entry into the Medicare market. However, the company also faces challenges, including a lack of access to capital through traditional means and the need to significantly increase its healthcare membership to achieve profitability. As of June 30, 2026, cash and cash equivalents stood at $1.30 million, down from $3.76 million at the end of 2025.

Looking ahead, management has expressed a commitment to pursuing strategic alternatives to enhance liquidity and operational capacity. This includes potential equity or debt financing, asset sales, or other strategic transactions. The company acknowledges the competitive landscape and regulatory complexities it faces but remains optimistic about its ability to execute its business plan and continue operations over the next twelve months. However, the success of these initiatives is contingent on various factors, including market conditions and the ability to attract and retain key personnel.